Tan Aik Na
SEC Form 4 insider trading activity
Tan Aik Na has filed 3 SEC Form 4 filings (14 transaction rows) across 1 company, with disclosures dating back to 2025. 3 of those filings fall inside the rolling window. Most recent filing: Oct 8, 2026.
On the most recent filing, Tan Aik Na is listed as Director at Wave Life Sciences, Inc. Inside the rolling window, Tan Aik Na reported no open-market purchases and 2 open-market sales totaling $1.6M in WVE. The largest disclosed transaction in the window is a sale of 113,218 WVE shares on Dec 8, 2025, worth $1.6M.
Companies traded
Other insiders at WVE
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.6M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Tan Aik Na made?
Tan Aik Na has filed 3 SEC Form 4 filings (14 transaction rows) across 1 company since 2025.
Which companies does Tan Aik Na trade?
Tan Aik Na has filed SEC Form 4 disclosures for 1 company, including WVE.
When was Tan Aik Na's most recent SEC Form 4 filing?
Tan Aik Na's most recent SEC Form 4 filing on Tracefour is dated Oct 8, 2026.
What is Tan Aik Na's total buy and sell value in the current window?
Inside the rolling retention window, Tan Aik Na bought $0 and sold $1.6M based on SEC Form 4 filings.
What was Tan Aik Na's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 113,218 WVE shares on 2025-12-08, worth $1.6M, per SEC Form 4 filings.